Luminesce Alliance supported a psychosocial study that explores how precision medicine is changing the roles of healthcare professionals, scientists, and research staff. This recent published paper reports on the study and the data that was collected via PRISM-Impact, a psychosocial study running alongside the PRecISion Medicine for Children with Cancer (PRISM) trial. The PRISM trial is embedded in the Zero Childhood Cancer program.

The paper reveals that although many of the 85 participants described experiencing great emotional stress, lack of formal training and unique challenges, most however expressed very positive views about the impact of precision medicine on their profession and its future potential.